Transient ischemia of the retina results in altered retrograde axoplasmic transport: neuroprotection with brimonidine

Exp Neurol. 2002 Dec;178(2):243-58. doi: 10.1006/exnr.2002.8043.

Abstract

In adult rats we have induced retinal ischemia and investigated retrograde axonal transport in ganglion cells. The animals received in their left eyes, 1 h prior to ischemia, two 5-microl drops of saline or 0.5% brimonidine (BMD). Retinal ischemia was induced by transient ligature of the left ophthalmic vessels for 90 min. One hour or 1 week after ischemia, Fluorogold (FG) was applied to both superior colliculi, the animals were processed 1 week after FG application, and FG-labeled retinal ganglion cell (RGC) densities were estimated in the right control and left experimental retinas. In the left retinas of the saline-pretreated animals, RGC densities diminished to 39 or 30% of the densities found in their right control retinas, 7 or 14 days after ischemia, respectively. Because in a previous similar study in which FG was applied 7 days before ischemia, the percentages of FG-labeled RGCs were 54 and 48%, 7 and 14 days after ischemia, respectively, this suggests that retrograde axonal transport was impaired in some surviving RGCs. This was confirmed in an additional group of rats in which 1,1'-dioctadecyl-3,3,3',3'-tetramethylindocarbocyanine perchlorate was applied to both SCi 3 weeks before ischemia, and FG was applied to the intraorbitally cut optic nerve 9 days after ischemia and 5 days before euthanization. In the left retinas of the BMD-pretreated animals, RGC densities amounted to 90% of the RGC population 7 or 14 days after ischemia and were comparable to those obtained in their contralateral nonischemic retinas. Retinal ischemia causes RGC loss and induces alterations of retrograde axonal transport in a proportion of surviving RGCs. BMD rescues RGCs from ischemia-induced cell death and preserves retrograde axonal transport in surviving RGCs.

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Axonal Transport* / drug effects
  • Axonal Transport* / physiology
  • Axons / drug effects
  • Axons / pathology*
  • Brimonidine Tartrate
  • Female
  • Fluorescent Dyes / pharmacokinetics
  • In Vitro Techniques
  • Ischemic Attack, Transient / drug therapy*
  • Ischemic Attack, Transient / physiopathology*
  • Neuroprotective Agents / pharmacology
  • Neuroprotective Agents / therapeutic use*
  • Quinoxalines / pharmacology
  • Quinoxalines / therapeutic use*
  • Rats
  • Rats, Sprague-Dawley
  • Retina / drug effects
  • Retina / physiopathology*

Substances

  • Fluorescent Dyes
  • Neuroprotective Agents
  • Quinoxalines
  • Brimonidine Tartrate